EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 53 filers reported holding EDGE THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | -100.0% | 1,115 | -51.5% | 0.00% | – |
| Q3 2018 | $2,000 | -96.6% | 2,301 | -96.0% | 0.00% | – |
| Q2 2018 | $58,000 | +7.4% | 57,457 | +26.4% | 0.00% | – |
| Q1 2018 | $54,000 | -88.2% | 45,457 | -6.6% | 0.00% | – |
| Q4 2017 | $456,000 | -0.9% | 48,645 | +13.3% | 0.00% | – |
| Q3 2017 | $460,000 | +62.0% | 42,951 | +55.1% | 0.00% | – |
| Q2 2017 | $284,000 | -28.6% | 27,695 | -36.6% | 0.00% | – |
| Q1 2017 | $398,000 | -66.9% | 43,686 | -54.7% | 0.00% | – |
| Q4 2016 | $1,204,000 | +412.3% | 96,374 | +327.4% | 0.00% | – |
| Q3 2016 | $235,000 | +13.0% | 22,549 | +9.8% | 0.00% | – |
| Q2 2016 | $208,000 | +18.9% | 20,529 | +7.1% | 0.00% | – |
| Q1 2016 | $175,000 | +280.4% | 19,174 | +426.9% | 0.00% | – |
| Q4 2015 | $46,000 | – | 3,639 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,344,868 | $24,058,000 | 16.90% |
| VHCP Management II, LLC | 1,933,582 | $19,839,000 | 7.92% |
| ACUTA CAPITAL PARTNERS, LLC | 1,504,612 | $15,437,000 | 4.32% |
| Opaleye Management Inc. | 130,000 | $1,334,000 | 0.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,000 | $1,539,000 | 0.26% |
| DAFNA Capital Management LLC | 19,400 | $199,000 | 0.14% |
| REGENTATLANTIC CAPITAL LLC | 134,900 | $1,384,000 | 0.13% |
| MARK SHEPTOFF FINANCIAL PLANNING, LLC | 14,400 | $148,000 | 0.10% |
| TFS CAPITAL LLC | 20,080 | $206,000 | 0.08% |
| EAGLE ASSET MANAGEMENT INC | 901,359 | $9,247,000 | 0.06% |